Top Markets
#1 Black Phoenix Black Phoenix +355.39%
#2 Glidr Glidr +84.34%
#3 Gold Park Gold Park +62.70%
#4 Akedo Akedo +55.10%
#5 OpenEden OpenEden +54.44%
#6 BasedHype BasedHype +27.45%
#7 Avantis Avantis +21.78%
#8 Cryptopia Cryptopia +21.54%
#9 Acurast Acurast +19.36%
#10 Humanity Humanity +17.48%
Coin of the day
Black Phoenix Black Phoenix
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
Verisante Technology Inc. Verisante Technology Inc.

Verisante Technology Inc.

VRSEF
Kedudukan dalam Saham #40371
Verisante Technology Inc. presently lacks substantial business operations.... Verisante Technology Inc. presently lacks substantial business operations. Historically, the company focused on developing and manufacturing advanced diagnostic devices for cancer. Originally founded as T-Ray Science Inc., it adopted its current name, Verisante Technology Inc., in January 2011. The firm was established in 2006 and is headquartered in Vancouver, Canada.
Harga Saham
$0.0011
Disegerakkan terakhir: 2026-08-12
Modal Pasaran
$164.53K
Perubahan (1 hari)
0.00%
Perubahan (1 tahun)
-72.50%
Negara
CA
Perdagangan Verisante Technology Inc. (VRSEF)

Kategori

Healthcare
Nisbah P/S bagi Verisante Technology Inc. (VRSEF)
Nisbah P/S pada 2026 TTM: 0
Menurut laporan kewangan dan harga saham terkini Verisante Technology Inc., nisbah P/S semasa (TTM) ialah 0. Pada akhir 2026, nisbah P/S syarikat ialah 0.
Sejarah nisbah P/S untuk Verisante Technology Inc. dari 2026 hingga 2026
Nisbah P/S pada akhir setiap tahun
Tahun Nisbah P/S Ubah
Tidak cukup data untuk tarikh yang disediakan.
Nisbah P/S untuk syarikat atau pesaing yang serupa
Syarikat Nisbah P/S Perbezaan Nisbah P/S Negara
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
3.95 -
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
4.83 -
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
2.78 -
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
3.31 -
US
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
Edwards Lifesciences Corporation
EW.US
7.61 -
US